Laura Prendergast

Stock Analyst at Raymond James

(n/a)
# 4,841
Out of 4,883 analysts
9
Total ratings
12.5%
Success rate
-35%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Laura Prendergast

Erasca
Mar 26, 2025
Initiates: Outperform
Price Target: $5
Current: $1.45
Upside: +244.83%
Third Harmonic Bio
Feb 11, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $5.41
Upside: -
Mural Oncology
Oct 4, 2024
Initiates: Strong Buy
Price Target: $18
Current: $2.51
Upside: +617.13%
Nkarta
Aug 14, 2024
Upgrades: Strong Buy
Price Target: $16
Current: $1.74
Upside: +819.54%
Black Diamond Therapeutics
Jul 31, 2024
Initiates: Outperform
Price Target: $20
Current: $2.60
Upside: +669.23%
Revolution Medicines
Apr 10, 2024
Upgrades: Strong Buy
Price Target: $36$48
Current: $37.19
Upside: +29.08%